lumateperone — United Healthcare
schizophrenia
Initial criteria
- Diagnosis of schizophrenia OR diagnosis of depressive episodes associated with bipolar I or II disorder (bipolar depression)
Reauthorization criteria
- Documentation of a positive clinical response to therapy
Approval duration
12 months